OCT 03, 2019 1:30 PM PDT

Re-examining the ethical & regulatory dimensions of gene editing in the wake of the "CRISPR babies" scandal

Presented at: CRISPR 2019
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Academic Associate / Lawyer, Centre of Genomics and Policy, McGill University
    Biography
      Erika Kleiderman is a lawyer and an Academic Associate at the Centre of Genomics and Policy (CGP) at McGill University. She holds a civil law degree (LL.B.) from the Université de Montréal, as well as a B.Sc. in Psychology from McGill University. She was called to the Quebec Bar in 2014. Currently, her research deals with the ethical, legal, and social implications surrounding access to data and genetic information, biobanking, and the regulation of stem cells, regenerative medicine, and new reproductive technologies. Erika is engaged in the stem cell and regenerative medicine community through her involvement with the Stem Cell Network's Trainee Communications and Training & Education Committees, as well as through her coordination role in the pan-Canadian initiative aimed at assessing the adequacy of existing regulatory frameworks and considerations for reframing the Assisted Human Reproduction Act, in light of evolving reproductive technologies. She is also the Coordinator of the Canadian International Data Sharing Initiative (Can-SHARE) and the Access Officer of the Canadian Partnership for Tomorrow Project (CPTP), for which she has been actively involved in the development of controlled data and biosample access documentation and operating procedures. Erika is also interested in the potential applications of gene editing for performance enhancement (gene doping), as well as the implications of gene therapy and enhancement in minors within a sporting context. She is also a member of the McGill University Health Centre Research Ethics Board.

    Abstract

    Over the last decade, the policy and regulatory trajectory of genomic and reproductive technologies has been a checkered one. Approaches around the world range from constitutional and criminal prohibitions, to statutory intervention, moratoria, or, professional guidance sometimes combined with regulatory oversight. These debates have been reignited following the announcement of the births of the “CRISPR babies” back in November 2018. They raise a range of ethical, legal and social issues that can in turn have an impact on how we choose to regulate and oversee disruptive technologies. In this presentation, I will begin by providing an overview of the current international legal and policy landscape surrounding heritable genome editing. Then, I will present some of the ethical failures or shortcomings of the “CRISPR babies” scandal and the steps that have been taken to further the discussion following this, both in China and internationally. I also discuss the impact of this event for Canada, and conclude by considering questions surrounding the feasibility of moratoria in this context and more broadly, ‘where do we go from here’.

    Learning objectives:

    1. Gain a better understanding of the legal and regulatory frameworks surrounding heritable genome editing.
    2. Highlight key ethical failures arising in the wake of the “CRISPR babies”.
    3. Consider important elements of a responsible translation pathway regarding potential clinical applications of human genome editing.
    4. Consider the potential impact of a moratorium on the advancement (or not) of the field.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    APR 21, 2021 5:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    APR 21, 2021 5:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
    OCT 03, 2019 1:30 PM PDT

    Re-examining the ethical & regulatory dimensions of gene editing in the wake of the "CRISPR babies" scandal

    Presented at: CRISPR 2019
    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Immunology

    Molecular Biology

    Cell Biology

    Pcr/rt-Pcr/real-Time Pcr

    Cell Culture

    Gene Expression

    Clinical Diagnostics

    Immunity

    Tumor

    Cancer

    Microbiology

    Biochemistry

    Dna

    T-Cells

    Biomarkers

    Geography

    North America43%

    Asia29%

    Europe29%

    Registration Source

    Website Visitors100%

    Job Title

    Educator/Faculty40%

    Student40%

    Research Scientist20%

    Organization

    Academic Institution71%

    Research Institute14%

    Other14%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more